Westmead Dermatology Striving towards disease-free skin
Psoriasis is a chronic inflammatory skin disease. Patients with psoriasis are predisposed to cardiovascular problems, diabetes, depression and arthritis. At Westmead Hospital we have a free information evening on Thursday 20th of November 2014 (6.00 to 8.30pm). If you are suffering from psoriasis or have a family member or friend with psoriasis and want to …
Skin cancers are so prevalent in Australia and we should educate ourselves (and those around us) on some simple detection and prevention techniques. Last week, Prof Pablo Fernandez-Penas was invited on “Today” to discuss methods for early detection and avoiding skin cancer. A baseline skin check should be conducted with a dermatologist first. Subsequent self-examination …
The impact of skin conditions in the quality of life of dermatology patients is usually unappreciated by many physicians, and it is one of our areas of interest. We have several projects evaluating different instruments and assessments. At the Skin and Cancer Foundation Australia a group of very keen medical students are working with our …
The research unit of the department of Dermatology consists of following staff: Head of Department: A/Prof Fernandez-Penas Research Unit Manager: Dr Marina Ali Research Associates: Dr Giuliana Carlos, Dr Bonita Choy, Dr Deepal Deshpande PhD students: Dr Rachael Anforth and Mr Ali Azimi Admin Officer: Mrs Saigeetha Iyer Honorary researchers: Dr Flavia Senetiner and Dr …
Aside from melanoma, we are also involved with research into non-melanoma skin cancer (NMSC) prevention and management. NMSC are the most common type of cancers in Australia and while most are not life threatening, it is an important condition which accounts for a high rate of hospitalisations in Australia each year. As part of our …
Since 2010, the Advanced Melanoma Clinic in our department has been receiving referrals from the Crown Princess Mary Cancer Centre. We review patients on melanoma trials using single BRAF, MEK inhibitors or the combination of both drugs. Patients are followed up throughout their treatment. The assessments included: full skin examination, dermoscopy and full body photography. …
We have a new paper on the cutaneous adverse events of BRAF inhibitor based therapies in patients with metastatic malignant melanoma. It is fantastic that patients are surviving more than 1 year with these therapies, but dermatologists and oncologists should be aware that side effects from these medications are still present and need to be …
Australia has the highest melanoma incidence in the world with certain subpopulations known to be at extreme risk. Early detection of primary melanoma of the skin is critical in reducing associated mortality. In the department of Dermatology Westmead Hospital we have recently started a study in collaboration with RPA Hospital and the Melanoma Institute of …
